Table 4 Amiodarone therapy summary
Parameter | No AF recurrence (n = 86) | AF recurrence (n = 91) | Total (n = 177) | P |
|---|---|---|---|---|
Amiodarone boluses | Â | Â | Â | 0.07 |
 0 | 43 (42) | 19 (25) | 62 (35) | |
 1 | 51 (50) | 47 (61) | 98 (55) | |
 2 | 5 (5) | 7 (9) | 12 (7) | |
 3 | 2 (2) | 3 (4) | 5 (3) | |
Amiodarone dosing | Â | Â | Â | <0.001 |
 Bolus only | 3 (3) | 20 (23) | 23 (13) | |
 Infusion only | 43 (43) | 19 (25) | 62 (35) | |
 Bolus and infusion | 40 (47) | 52 (57) | 92 (52) | |
Delay to infusion after bolus (hours) | 2 (1–3) (n = 29) | 2 (1–6) (n = 45) | 2 (1–4) (n = 74) | 0.48 |
Total dose amiodarone (mg) | 702 (300–1117) | 1366 (752–2711) | 905 (488–1651) | <0.001 |
Infusion time (hours) | 20 (12–28) | 31 (20–58) | 24 (16–40) | <0.001 |
Continuing to receive inotropes with amiodarone ceased | 0 (0) (n = 2) | 23 (66) (n = 35) | 37 (100) (n = 37) | 0.14 |